U.S. FDA Renews DILIsym® Software Licenses for 7th Year
Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals ...
Stay updated with breaking news from Simulations Plus Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Predicting DILI risk supports informed decision-making regarding drug evaluations and approvals ...
U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.
Shares of Flora Growth Corp. (NASDAQ: FLGC) fell sharply in today’s pre-market trading after the company reported the launch of proposed underwritten public offering of common shares.
Simulations Plus, Inc. beats earnings expectations. Reported EPS is $0.1983, expectations were $0.18. Simulations Plus, Inc.
-- Technology stocks were rising premarket Thursday, with the Technology Select Sector SPDR Fund gaining 0.4% while the SPDR S&P Semiconductor ETF was flat. Simulations Plus surged past 10% after...